ALNYLAM PHARMACEUTICALS Executives Sell Shares

2026-03-07 16:53:51

Abstract generation in progress

Several top executives at ALNYLAM PHARMACEUTICALS, including the Chief Commercial Officer, Chief Financial Officer, Chief Executive Officer, and EVP Chief R&D, have sold shares of the company’s common stock. These sales were part of mandatory sell-to-cover provisions for tax obligations upon the vesting of restricted stock units. The total value of shares sold by these executives exceeds $4 million.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.